Compound Report Overview
Compound Name:
PD-153035
Compound Identifier:
707457
Mol Structure 2D:
707457
Molecular Weight:
360
Formula:
C16 H14 Br N3 O2
Development Status:
Clinical Phase I
SMILES:
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC